Frontiers in Immunology,
Год журнала:
2025,
Номер
16
Опубликована: Апрель 8, 2025
Human
papillomavirus
(HPV),
a
double-stranded
DNA
virus
linked
to
various
malignancies,
poses
significant
global
public
health
challenge.
In
cervical
cancer,
persistent
infection
with
high-risk
HPV
genotypes,
particularly
HPV-16
and
HPV-18,
initiates
immune
evasion
mechanisms
within
the
tumor
microenvironment.
The
polarization
of
tumor-associated
macrophages
(TAMs)
from
M1
M2
phenotypes
promotes
carcinogenesis,
metastasis,
therapeutic
resistance
via
establishing
an
immunosuppressive
This
review
provides
comprehensive
overview
HPV-induced
pathways,
including
MHC
downregulation,
T-cell
impairment,
regulatory
T
cell
induction,
cGAS-STING
pathway
inhibition.
Furthermore,
describe
pivotal
role
TAMs
in
cancer
progression,
focusing
on
their
phenotypic
plasticity,
pro-tumoral
functions,
potential
as
targets.
By
elucidating
these
cellular
molecular
dynamics,
this
aims
support
advanced
research.
Targeting
TAM
through
immunotherapies
nanomedicine-based
strategies
represents
promising
strategy
for
enhancing
patient
outcomes.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Март 17, 2023
Hepatocellular
carcinoma
(HCC)
is
a
complex
disease
with
poor
outlook
for
patients
in
advanced
stages.
Immune
cells
play
an
important
role
the
progression
of
HCC.
The
metabolism
sphingolipids
functions
both
tumor
growth
and
immune
infiltration.
However,
little
research
has
focused
on
using
sphingolipid
factors
to
predict
HCC
prognosis.
This
study
aimed
identify
key
genes
(SPGs)
develop
reliable
prognostic
model
based
these
genes.The
TCGA,
GEO,
ICGC
datasets
were
grouped
SPGs
obtained
from
InnateDB
portal.
A
gene
signature
was
created
by
applying
LASSO-Cox
analysis
evaluating
it
Cox
regression.
validity
verified
GEO
datasets.
microenvironment
(TME)
examined
ESTIMATE
CIBERSORT,
potential
therapeutic
targets
identified
through
machine
learning.
Single-cell
sequencing
used
examine
distribution
within
TME.
Cell
viability
migration
tested
confirm
SPGs.We
28
that
have
impact
survival.
Using
clinicopathological
features
6
genes,
we
developed
nomogram
high-
low-risk
groups
found
distinct
characteristics
response
drugs.
Unlike
CD8
T
cells,
M0
M2
macrophages
be
highly
infiltrated
TME
high-risk
subgroup.
High
levels
good
indicator
immunotherapy.
In
cell
function
experiments,
SMPD2
CSTA
enhance
survival
Huh7
while
silencing
increased
sensitivity
lapatinib.The
presents
six-gene
can
aid
clinicians
choosing
personalized
treatments
patients.
Furthermore,
uncovers
connection
between
sphingolipid-related
microenvironment,
offering
novel
approach
By
focusing
crucial
like
CSTA,
efficacy
anti-tumor
therapy
cells.
Bioactive Materials,
Год журнала:
2024,
Номер
36, С. 126 - 156
Опубликована: Март 2, 2024
Small
extracellular
vesicles
(sEVs)
are
known
to
be
secreted
by
a
vast
majority
of
cells.
These
sEVs,
specifically
exosomes,
induce
specific
cell-to-cell
interactions
and
can
activate
signaling
pathways
in
recipient
cells
through
fusion
or
interaction.
nanovesicles
possess
several
desirable
properties,
making
them
ideal
for
regenerative
medicine
nanomedicine
applications.
properties
include
exceptional
stability,
biocompatibility,
wide
biodistribution,
minimal
immunogenicity.
However,
the
practical
utilization
particularly
clinical
settings
at
large
scale,
is
hindered
expensive
procedures
required
their
isolation,
limited
circulation
lifetime,
suboptimal
targeting
capacity.
Despite
these
challenges,
sEVs
have
demonstrated
remarkable
ability
accommodate
various
cargoes
found
extensive
applications
biomedical
sciences.
To
overcome
limitations
broaden
potential
applications,
researchers
should
strive
deepen
understanding
current
loading,
characterization
techniques.
Additionally,
acquiring
fundamental
knowledge
about
origins
employing
state-of-the-art
methodologies
expand
research
scope.
This
review
provides
comprehensive
overview
exosome-based
strategies
diverse
domains,
encompassing
cancer
therapy,
immunotherapy,
biomarker
Furthermore,
we
emphasize
immense
exosomes
medicine.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Сен. 11, 2023
Regulatory
T
cells
(Treg),
as
members
of
CD4+
cells,
have
garnered
extensive
attention
in
the
research
tumor
progression.
Treg
function
inhibiting
immune
effector
preventing
tissue
damage,
and
suppressing
inflammation.
Under
stimulation
inflammatory
microenvironment
(IM),
reprogramming
enhances
their
suppression
responses,
ultimately
promoting
escape
or
Reducing
number
IM
lowering
activity
while
reprogramming,
can
help
promote
body's
anti-tumor
responses.
This
review
introduces
a
mechanism
IM;
discusses
regulation
on
The
control
response
to
immunotherapy
are
analyzed
countermeasures
proposed.
work
will
provide
foundation
for
downregulating
immunosuppressive
role
environment
future
immunotherapy.
Aging,
Год журнала:
2023,
Номер
15(19), С. 10305 - 10329
Опубликована: Окт. 4, 2023
Background:
Research
on
immunogenic
cell
death
(ICD)
in
lung
adenocarcinoma
(LUAD)
has
been
relatively
limited.
This
study
aims
to
create
ICD-related
signatures
for
accurate
survival
prognosis
prediction
LUAD
patients,
addressing
the
challenge
of
lacking
reliable
early
prognostic
indicators
this
type
cancer.
Methods:
Using
single-cell
RNA
sequencing
(scRNA-seq)
analysis,
ICD
activity
cells
was
calculated
by
AUCell
algorithm,
divided
into
high-
and
low-ICD
groups
according
median
values,
key
regulatory
genes
were
identified
through
differential
these
integrated
TCGA
data
construct
using
LASSO
COX
regression
multi-dimensional
analysis
terms
prognosis,
immunotherapy,
tumor
microenvironment
(TME),
mutational
landscape.
Results:
The
constructed
signature
reveals
a
pronounced
disparity
between
low-risk
patients.
statistical
discrepancies
times
among
patients
from
both
GEO
databases
further
corroborate
observation.
Additionally,
heightened
levels
immune
infiltration
expression
are
evidenced
group,
suggesting
potential
benefit
immunotherapeutic
interventions
pivotal
risk-associated
tissue
samples
assessed
utilizing
qRT-PCR,
thereby
unveiling
PITX3
as
plausible
therapeutic
target
context
LUAD.
Conclusions:
Our
provide
help
predicting
immunotherapy
some
extent
guide
clinical
treatment
Microsystems & Nanoengineering,
Год журнала:
2023,
Номер
9(1)
Опубликована: Окт. 5, 2023
Abstract
With
the
annual
increases
in
morbidity
and
mortality
rates
of
tumors,
use
biomarkers
for
early
diagnosis
real-time
monitoring
tumor
cells
is
great
importance.
Biomarkers
used
cell
detection
body
fluids
include
circulating
cells,
nucleic
acids,
protein
markers,
extracellular
vesicles.
Among
them,
DNA,
exosomes
have
high
potential
prediction,
diagnosis,
prognosis
diseases
due
to
large
amount
valuable
information
on
characteristics
evolution;
addition,
situ
telomerase
miRNA
living
has
been
topic
extensive
research
understand
development
real
time.
Various
techniques,
such
as
enzyme-linked
immunosorbent
assays,
immunoblotting,
mass
spectrometry,
widely
these
markers.
markers
based
electrochemical
biosensors
fluorescence
signal
analysis
highly
preferred
because
its
sensitivity,
rapid
portable
operation.
Herein,
we
summarize
recent
progress
using
biosensors,
outline
current
status
discuss
technical
challenges
their
practical
clinical
application
provide
a
reference
new
marker
methods.
International Journal of Nanomedicine,
Год журнала:
2024,
Номер
Volume 19, С. 3657 - 3675
Опубликована: Апрель 1, 2024
Abstract:
Exosomes
are
extracellular
vesicles
that
originate
from
various
cells
and
mediate
intercellular
communication,
altering
the
behavior
or
fate
of
recipient
cells.
They
carry
diverse
macromolecules,
such
as
lipids,
proteins,
carbohydrates,
nucleic
acids.
Environmental
stressors
can
change
exosomal
contents
many
cells,
making
them
useful
for
diagnosing
chronic
disorders,
especially
neurodegenerative,
cardiovascular,
cancerous,
diabetic
diseases.
Moreover,
exosomes
be
engineered
therapeutic
agents
to
modulate
disease
processes.
State-of-art
techniques
employed
separate
including
ultracentrifugation,
size-exclusion
chromatography
immunoaffinity.
However,
modern
technologies
aqueous
two-phase
system
well
microfluidics
gaining
attention
in
recent
years.
The
article
highlighted
composition,
biogenesis,
implications
exosomes,
standard
novel
methods
isolating
applying
biomarkers
cargo
carriers.
Keywords:
Exosomes,
vesicles,
biomarkers,
carriers,
separation
Frontiers in Immunology,
Год журнала:
2024,
Номер
14
Опубликована: Янв. 3, 2024
Extracellular
vesicles
(EVs)
have
been
proven
to
play
a
significant
immunoregulatory
role
in
many
chronic
diseases,
such
as
cancer
and
immune
disorders.
Among
them,
EVs
derived
from
NK
cells
are
an
essential
component
of
the
cell
functions.
These
demonstrated
carry
variety
toxic
proteins
nucleic
acids
therapeutic
diseases
like
malignancies,
liver
fibrosis,
lung
injury.
However,
natural
NK-derived
(NKEVs)
certain
limitations
disease
treatment,
low
yield
poor
targeting.
Concurrently,
exhibit
characteristics
memory-like
cells,
which
stronger
proliferative
capacity,
increased
IFN-γ
production,
enhanced
cytotoxicity,
making
them
more
advantageous
for
treatment.
Recent
research
has
shifted
its
focus
towards
engineered
extracellular
their
potential
improve
efficiency,
specificity,
safety
treatments.
In
this
review,
we
will
discuss
latest
advancements
therapy.
Specifically,
compare
different
cellular
sources
NKEVs
explore
current
status
prospects
cell-derived
NKEVs.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics,
Год журнала:
2024,
Номер
32(3), С. 563 - 576
Опубликована: Янв. 1, 2024
Glycogen
metabolism
plays
a
key
role
in
the
development
of
hepatocellular
carcinoma
(HCC),
but
function
glycogen
genes
tumor
microenvironment
(TME)
is
still
to
be
elucidated.
Single-cell
RNA-seq
data
were
obtained
from
ten
HCC
samples
totaling
64,545
cells,
and
65
analyzed
by
nonnegative
matrix
factorization
(NMF).
The
prognosis
immune
response
new
TME
cell
clusters
predicted
using
immunotherapy
cohorts
public
databases.
single-cell
analysis
was
divided
into
fibroblasts,
NT
T
macrophages,
endothelial
B
which
separately
gene
annotation.
Pseudo-temporal
trajectory
demonstrated
temporal
differentiation
different
subtype
clusters.
Cellular
communication
revealed
extensive
interactions
between
cells
with
metabolizing
cell-related
subtypes
SCENIC
transcription
factors
upstream
metabolism.
In
addition,
found
enriched
expression
CAF
subtypes,
CD8
depleted,
M1,
M2
types.
Bulk-seq
showed
prognostic
significance
metabolism-mediated
HCC,
while
significant
cohort
patients
treated
checkpoint
blockade
(ICB),
especially
for
CAFs,
macrophages.
summary,
our
study
reveals
first
time
that
mediates
intercellular
elucidating
anti-tumor
mechanisms
responses
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Авг. 21, 2023
Regulatory
T
cells
(Tregs),
are
a
key
class
of
cell
types
in
the
immune
system.
In
tumor
microenvironment
(TME),
presence
Tregs
has
important
implications
for
response
and
development.
Relatively
little
is
known
about
role
lung
adenocarcinoma
(LUAD).Tregs
were
identified
using
but
single-cell
RNA
sequencing
(scRNA-seq)
analysis
interactions
between
other
TME
investigated.
Next,
we
used
multiple
bulk
RNA-seq
datasets
to
construct
risk
models
based
on
marker
genes
explored
differences
prognosis,
mutational
landscape,
infiltration
immunotherapy
high-
low-risk
groups,
finally,
qRT-PCR
function
experiments
performed
validate
model
genes.The
cellchat
showed
that
MIF-(CD74+CXCR4)
pairs
play
interaction
with
subpopulations,
Tregs-associated
signatures
(TRAS)
could
well
classify
LUAD
cohorts
into
groups.
Immunotherapy
may
offer
greater
potential
benefits
group,
as
indicated
by
their
superior
survival,
increased
cells,
heightened
expression
checkpoints.
Finally,
experiment
verified
LTB
PTTG1
relatively
highly
expressed
cancer
tissues,
while
PTPRC
was
paracancerous
tissues.
Colony
Formation
assay
confirmed
knockdown
reduced
proliferation
ability
cells.TRAS
constructed
scRNA-seq
distinguish
patient
subgroups,
which
provide
assistance
clinical
management
patients.
Frontiers in Immunology,
Год журнала:
2023,
Номер
14
Опубликована: Авг. 31, 2023
Glioblastoma
(GBM)
is
a
malignant
primary
brain
tumor.
This
study
focused
on
exploring
the
exosome-related
features
of
glioblastoma
to
better
understand
its
cellular
composition
and
molecular
characteristics.Single-cell
RNA
sequencing
(scRNA-seq)
spatial
transcriptome
(stRNA-seq)
were
used
analyze
heterogeneity
glioblastomas.
After
data
integration,
cell
clustering,
annotation,
five
algorithms
calculate
scores
for
genes(ERGs).
Cell
trajectory
analysis
intercellular
communication
performed
explore
patterns.
Spatial
analyzed
validate
findings.
To
further
utilize
aid
in
clinical
decision-making,
prognostic
model
was
constructed
using
GBM's
bulk
RNA-seq.Different
subpopulations
observed
GBM,
with
Monocytes/macrophages
cells
tumor
samples
showing
higher
scores.
identifying
differentially
expressed
ERGs
cells,
pseudotime
revealed
status
during
development.
Intercellular
highlighted
signaling
pathways
ligand-receptor
interactions.
confirmed
high
expression
gene
core
region.
A
based
six
shown
be
predictive
overall
survival
immunotherapy
outcome
GBM
patients.
Finally,
results
scRNA-seq
modeling
as
well
series
function
experiments,
BARD1
identified
novel
target
treatment
GBM.This
provides
comprehensive
understanding
both
stRNA-seq,
exhibiting
stronger
Monocytes/macrophages.
In
terms
data,
highly
scored
also
concentrated
RNA-seq,
patients
index
exhibited
an
immunosuppressive
microenvironment,
which
accompanied
by
worse
prognosis
outcomes.
Prognostic
models
are
expected
independent
indicators
patients,
potential
implications
personalized
strategies
GBM.
Knockdown
lines
reduces
invasive
value-added
capacity
thus
BARD1-positively
expressing
risk
factor